Net Income

Beyond a simple date change for its $10M dividend, Dominari Holdings is signaling a major strategic shift, funded by investment gains and aimed at AI.

As winter storms loom, a silent threat enters our homes. Learn the critical, life-saving steps to protect your family from carbon monoxide and fire.

indie Semiconductor is aggressively using stock grants to lure top engineers for its ADAS future. But what is the cost of this talent war for investors?

A key 2026 legal forum reveals the DOJ's expanding False Claims Act focus, putting cybersecurity non-compliance and private equity investors on notice.

From biopharma to webcomics, shareholder lawsuits reveal the perils of misleading investors. A look at four companies facing legal and financial fallout.

Jiuzi Holdings announced a $4M offering, tanking its stock. Then, news of a $1B crypto funding plan sent it soaring. A deep dive into a high-stakes pivot.

Updated trial results for Lilly's Inluriyo-Verzenio combo extend life without chemo, positioning the firm for dominance in a competitive oncology market.

Amid a $2.37B buyout, Weiss Asset Management's increased stake in Avadel Pharma raises questions. Is it a vote of confidence or a strategic power play?

Greenway Technologies is leaving the lab. A new deal with a Native-owned firm aims to turn stranded gas into gold, but can the micro-plant economics work?

A deep dive into Perma-Pipe's record-breaking quarter, revealing a strategy of regional dominance and savvy diversification into high-growth tech sectors.

When a trusted professional evades over $1 million in taxes, the impact goes beyond the courtroom, shaking public trust and starving community services.

Nordic American Tankers is riding a wave of record profits, but the industry's future hinges on volatile markets and the shadow of Venezuelan oil.

Amid a major corporate overhaul, Emergent BioSolutions secures a key FDA approval, signaling a new era for the firm and for U.S. biodefense strategy.

A sustainable energy firm eyes $75M in fees from a $300M Ripple Labs share deal in South Korea. Is this a genius, capital-light move into crypto?

A positive EU opinion for Sobi's Aspaveli could bring the first-ever targeted treatment for two rare kidney diseases, shaking up a market desperate for innovation.

A prestigious TSMC award for Asahi Kasei's PIMEL™ material reveals a critical dependency in the AI chip supply chain and a major strategic bet.

Sidus Space CEO Carol Craig's appointment to the Canaveral Port Authority board signals a new era of synergy between Florida's sea and space industries.

A Chinese eco-tech firm is betting on India's infrastructure boom. Can its waste-to-value solutions capture a piece of this massive, competitive market?

With a $157M expansion, Hyosung aims to build the USA's largest transformer plant, tackling an energy crisis fueled by AI and an aging infrastructure.

Fresh off its IPO, iOThree is pushing AI and certified digital tools. Can its innovation engine and Asian expansion overcome market headwinds?